Home

PETER J GRAHAM

CIK 1235635 · Chief Legal Officer · last filed 2026-07-02

PETER J GRAHAM is a Chief Legal Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for ADCT, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$206.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $925.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$925.8K

Companies

4

Total Filings

32

Lifetime Open-Market Net

-$206.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADCT Chief Legal Officer 841,640 $1.10 $925.8K $0 5 2026-07-02
ANTARES PHARMA, INC. (ATRS) Delisted EVP General Counsel, Secretary 630,244 $5.59 $3.52M -$206.2K 20 2022-03-04
DCTH EVP; General Counsel 0 $11.72 $0 $0 5 2013-11-18
E-Z-EM, Inc. (EZEM) Delisted SVP - Chief Legal Officer 0 — — $0 1 2008-04-02

Recent Filings

32 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 ADCT Grant (A) +221,100 $0 EDGAR
2026-02-18 ADCT Mixed +261,506 $1.04M EDGAR
2025-12-09 ADCT Tax (F) −49,508 -$162.9K EDGAR
2025-02-14 ADCT Grant (A) +220,000 $354.2K EDGAR
2024-12-09 ADCT Tax (F) −41,458 -$129.8K EDGAR
2022-05-26 — Disp (D) −740,843 -$4.15M
2022-03-04 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +12,409 -$51.8K EDGAR
2022-02-18 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +9,769 -$48.7K EDGAR
2021-06-14 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +48,173 $211.8K EDGAR
2021-06-10 ANTARES PHARMA, INC. (ATRS) Delisted Tax (F) −15,996 -$70.2K EDGAR
Showing 1–10 of 32
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.